Clinical Trial

Individually Targeted Neuromodulation for Contamination-based OCD

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 15, 2024 (before its estimated June 30, 2024 completion). Its status may not reflect the trial's current state.
Summary
Patients with obsessive-compulsive disorder (OCD) experience a wide array of different types of obsessions and compulsions. However, current treatments for OCD employ a "one size fits all" approach and are used for all patients regardless of symptom type. In this project, the investigators propose to investigate whether a novel method of transcranial magnetic stimulation specifically reduces contamination/washing symptoms - one of the most common types of OCD.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2021-09-08; most recent amendment 2025-09-03.
Status change: Recruiting → Terminated 2025-06-03
Status change: Not Yet Recruiting → Recruiting 2022-06-27
Trial Details
NCT Number NCT05048251
Lead Sponsor Mclean Hospital
Collaborators: Massachusetts General Hospital
Conditions Obsessive-Compulsive Disorder
Enrollment 50 participants
Start Date 2022-07-01
Primary Completion 2024-06-30 (estimated)
Study Completion 2024-06-30 (estimated)
Updated on ClinicalTrials.gov 2024-03-15